Timo Minssen

Timo Minssen

Professor

ORCID: 0000-0002-3286-4888
1 - 25 ud af 63Pr. side: 25
Sortering: Titel

  1. en store løsning hedder vaccine. Så her er det hækkeløb af forhindringer, vi skal over, før vi har sådan en

    Timo Minssen

    23/04/2020

    1 Mediebidrag

    Presse/medie

  2. Why the GMO Regulations in Europe are ‘Not Fit for Purpose’

    Timo Minssen

    27/02/2019

    1 Mediebidrag

    Presse/medie

  3. WIPR podcast interview

    Timo Minssen

    29/09/2020

    1 Mediebidrag

    Presse/medie

  4. Ukraine medicine IP waiver becomes ‘matter of life or death’

    Timo Minssen

    16/06/2022

    1 Mediebidrag

    Presse/medie

  5. USA sætter jagten ind på industrien, (interview concerning EU and US procedures regarding pharmaceutical patent settlements).

    Timo Minssen

    08/01/2014

    1 Mediebidrag

    Presse/medie

  6. US reform plan for patents raises innovation concerns

    Timo Minssen

    09/07/2019

    1 Mediebidrag

    Presse/medie

  7. Topadvokats selvmord kan sende medicinspekulanter på pengejagt

    Timo Minssen

    17/05/2017

    1 Mediebidrag

    Presse/medie

  8. That Pill Is Watching You - Privacy And Hackability Of Ingestible Electronic Sensors

    Sara Gerke, Timo Minssen, Helen Yu & Glenn Cohen

    03/09/2019

    1 element af Mediedækning

    Presse/medie

  9. Studiecirkel på högsta nivå

    Timo Minssen

    03/10/2010

    1 Mediebidrag

    Presse/medie

  10. Små firmaer kan få et vanskeligt liv under den nye patentdomstol.

    Timo Minssen

    10/04/2014

    1 Mediebidrag

    Presse/medie

  11. Settling the conflict between public health and liberty once and for all

    Timo Minssen

    30/08/2020

    1 Mediebidrag

    Presse/medie

  12. Sara Gerke and Timo Minssen join Diana Samuel to discuss the European Commission’s white paper on artificial intelligence (published in February 2020), and the challenges of implementing the outlined approach in healthcare.

    Timo Minssen & Sara Gerke

    11/06/2020

    1 Mediebidrag

    Presse/medie

  13. Salg af vaccineproduktion har gjort os sårbare

    Timo Minssen

    16/03/2020

    1 Mediebidrag

    Presse/medie

  14. SWEDEN’s Response to COVID-19: A tale of trust, recommendations, and odorous nudges

    Timo Minssen

    12/05/2020

    1 Mediebidrag

    Presse/medie

  15. Russian patents grab deemed ‘act of war’

    Timo Minssen

    16/06/2022

    1 Mediebidrag

    Presse/medie

  16. Regulating digital health - 2020

    Timo Minssen

    01/04/2020

    1 Mediebidrag

    Presse/medie

  17. Professor: En coronavaccine skal udvikles hurtigt, men vi kan ikke slække for meget på sikkerheden

    Timo Minssen

    23/03/2020

    1 Mediebidrag

    Presse/medie

  18. Professor i sundhedsret: Er vi trygge ved at vaccineproduktion er ude af vores hænder?

    Timo Minssen

    19/03/2020

    1 Mediebidrag

    Presse/medie

  19. Preparing for Antimicrobial Resistance: Vision and Social Science Mission of the INAMRSS Network

    Timo Minssen

    11/12/2020

    1 Mediebidrag

    Presse/medie

  20. Podcast-interview: Unlocking the full potential of Open Innovation in the Life Sciences through a classification system, see: https://www.ebe-biopharma.eu/wp-content/uploads/2018/01/EBE_Open-Innovation-Podcast-3.mp3

    Timo Minssen & Niclas Nilsson

    14/12/2017

    1 Mediebidrag

    Presse/medie

  21. Pharma companies need data strategies more than ever following recent CJEU decisions

    Timo Minssen

    04/02/2020

    1 Mediebidrag

    Presse/medie

  22. Patentstrid fortsætter for Novo

    Timo Minssen

    05/08/2016

    1 Mediebidrag

    Presse/medie

  23. On antibiotics, capital gains, China, America’s civil war, unicorns, ties - Letters to the editor

    Jonathan Darrow & Timo Minssen

    25/05/2019

    1 Mediebidrag

    Presse/medie

  24. Obama-forslag truer Novo

    Timo Minssen

    16/02/2011

    1 Mediebidrag

    Presse/medie

  25. Når man blander kunstig intelligens med biomedicin, så er juraen essential - Interview with CeBIL Director Timo Minssen

    Timo Minssen

    11/10/2018

    1 Mediebidrag

    Presse/medie

Forrige 1 2 3 Næste

ID: 16150437